| 产品编号 | bs-1119R |
| 英文名称 | Rabbit Anti-PAF antibody |
| 中文名称 | 血小板活化因子抗体 |
| 别 名 | platelet-activating factor; 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine; 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine monohydrate; 2-Acetyl-1-hexadecyl-sn-glycero-3-phosphocholine; 3-sn-Phosphatidylcholine; 1-hexadecyl-2-acetyl, PAF(C16. |
| 产品类型 | 小分子抗体 |
| 研究领域 | 药物及化合物 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Rat (predicted: PAF) |
| 产品应用 | IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理论分子量 | .524kDa |
| 性 状 | Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated PAF |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 缓 冲 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存条件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 产品介绍 |
Platelet-activating factor, a compound that reduces inflammation by increasing permeability of blood vessels and contracting various involuntary muscles such as those in airways. It is a phospholipid with a wide range of proinflammatory actions, is immediately degraded and inactivated in vivo by PAF acetylhydrolase. SWISS: N/A CAS: 74389-68-7 血小板活化因子（platelet-activating factor，PAF）是一种内源性具有生物活性的磷脂。由中性粒细胞、血小板、肥大细胞、内皮细胞和巨噬细胞产生。除早期发现它有强烈引起血小板聚集和脱颗粒作用外，近年来的研究发现它还具有广泛的生物活性，作为一种独特的细胞因子参与体内多种生理、病理过程，包括激活中性粒细胞，使其聚集、趋化、释放氧自由基和白三烯，抑制T细胞增殖，刺激B细胞合成IgG和IgE，抑制心肌收缩力，增加血管通透性，引起体循环血压下降和肺动脉高压等。由于它具有广泛的高强度的生物活性，故PAF被认为是与过敏反应有关的关键性介质之一。 |
| 产品图片 |
Tissue/cell: rat colon tissue;4% Paraformaldehyde-fixed and paraffin-embedded
Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum) at 37℃ for 20 min
Incubation: Anti-PAF Polyclonal Antibody, Unconjugated(bs-1119R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody and DAB staining
|
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
